Several large population-based studies have reported that inflammatory biomarkers, such as CRP levels, were not associated with IMT but rather with plaque prevalence, whereas FEV1 showed no relationship with carotid plaque occurrence but was significantly correlated with IMT [46,47,48]. This evidence concerns the gene CRP and inflammatory myofibroblastic tumor.